Dr. Michelle Ann Anderson, MD

Dr. Anderson practices at Mayo Clinic Hospital - Phoenix in Phoenix, Arizona, part of Mayo Clinic.

Dr. Anderson's NPI, 1326120841, was assigned on October 20, 2006. Dr. Anderson graduated from Wayne State University School Of Medicine in 1993. Dr. Anderson's Arizona license number on file is 64734.

Dr. Anderson's primary practice is Mayo Clinic Hospital - Phoenix, at 5777 East Mayo Boulevard, Phoenix, AZ 85054 in Maricopa County. The practice phone is (480) 342-4201.

Dr. Anderson's primary practice is Mayo Clinic Hospital - Phoenix in Phoenix, Arizona, part of Mayo Clinic. Dr. Anderson is also affiliated with MyMichigan Medical Center Alma. The medical group on file is Mayo Clinic Arizona. Dmand AI also links Dr. Anderson to 1 more ambulatory surgery center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Anderson practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Anderson's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Anderson is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Anderson's licenses on file in 2 states: Arizona and Michigan.

Dmand AI lists acid reflux, colonoscopy, gastrointestinal bleeding, intestinal or bowel obstruction, irritable bowel syndrome (IBS), pancreas or bile duct endoscopy (ERCP), peptic ulcer and upper GI endoscopy among the conditions Dr. Anderson treats.

CMS data shows 423 Medicare services from Dr. Anderson across 16 procedure codes in 2024, for 255 Medicare patients. Medicare paid $57,249 for them.

CMS counts 255 Medicare patients who saw Dr. Anderson in 2024. The largest group is 65 to 74, with 127 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Anderson's median patient age at 69, with 49% women.

In 2024, Dr. Anderson wrote 121 Medicare Part D claims for 74 patients. 78% of them were for generic drugs. CMS names the drug for 58 of them, across 3 drugs with 11 or more claims each, at $744 in total drug cost. In 2023, CMS named 44 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Anderson for performance year 2024, reported as part of a group. Dr. Anderson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Anderson as offering telehealth. CMS counts 383 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Anderson, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 65 papers to Dr. Anderson, published from 2007 to 2024. 2015 was the busiest year, with 4. The most frequent topics are Pancreatic Neoplasms, Pancreatitis, Chronic and Biomarkers, Tumor. Dr. Anderson has published most often in Gastrointest Endosc. Dr. Anderson's most frequent co-authors are Andres Gelrud, MD, Randall E. Brand and Michele D. Lewis, MD.

Dmand AI links Dr. Anderson to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Duodenal Neoplasms, Pancreatic Cyst and Lip Neoplasms.

CMS Open Payments shows 52 general payments to Dr. Anderson from 10 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 55% of the total. Boston Scientific Corporation paid the most, $21,798. It also lists 1 research payment totaling $524 in 2018.

Dmand AI lists 1 award for Dr. Anderson, most recently CMS Stage 1 EHR in 2013.

Dr. Anderson graduated from Wayne State University School Of Medicine in 1993. Dr. Anderson is a member of ACG, AGA and ASGE.

Dr. Anderson is in network with 8 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.